A New Wearable Smart Device To Measure Sugar Level, Stress And Inflammation From The Sweat
The scientists at the University of Texas, the United States have developed a new wearable device to measure sugar (glucose) level in the sweat for every one hour and up to one week. The device is costing between 10 and 15 cents.
The inbuilt sensors in the wearable device can help patients of diabetes in managing the symptoms and also can help the healthcare professionals in providing better treatment options to patients with diabetes.
The authors of the study say that the cortisol level will increase with chronic stress. The increase in the cortisol level can increase insulin resistance. The increased insulin resistance will keep the blood sugar (glucose) at a higher level and can increase the risk of type 2 diabetes (T2D) in a patient. The body organs will be affected by the inflammation associated with type 2 diabetes (T2D).
The device was designed to work on all types of skin without sacrificing the performance of the device. The device uses a gel, known as an ionic liquid, which can help the skin in stabilizing the microenvironment. The wearable device can be connected to a smartphone App and the data can be sent to the healthcare professionals.
The lead author of the study was Shalini Prasad, Associate professor of bioengineering, the University of Texas, Dallas, United States. The study was published on June 8, 2017, in the Scientific Reports. Title of the article was "A new paradigm in sweat based wearable diagnostics biosensors using Room Temperature Ionic Liquids (RTILs)"."
Obstructive Sleep Apnea (Apnoea. OSA) Can Increase The Risk Of Diabetic Retinopathy In Patients With Type 2 Diabetes
A study at the University of Birmingham, Birmingham, the United Kingdom shows an increased risk of vision due to the diabetic retinopathy with obstructive sleep apnea (apnoea. OSA) in patients of type 2 diabetes (T2D). They say that obstructive sleep apnea (OSA) is an independent predictor for the progression of diabetic retinopathy (an eye disease).
The 43 months follow-up study on about 230 patients with type 2 diabetes (T2D) shows that higher incidence of diabetic retinopathy in those patients with obstructive sleep apnea when compared with those patients with no obstructive sleep apnea. They found a higher risk of the development of severe diabetic retinopathy among type 2 diabetes (T2D) patients with obstructive sleep apnea (OSA).
They advise healthcare professionals to test for obstructive sleep apnea (OSA) in patients with diabetes as this condition is common.
The corresponding author of the study was Dr. Abd A Tahrani, NIHR Clinician Scientist, the University of Birmingham. The study was published on June 8, 2017, in the American Journal of Respiratory and Critical Care Medicine. Title of the article was "Obstructive Sleep Apnoea and Retinopathy in Patients with Type 2 Diabetes: A Longitudinal Study".
The CPAP machine can eliminate the snoring, can prevent the collapse of the airway and obstructed breathing (apneic) during sleep.
There are no serious side effects with the use of the CPAP machines. But some patients may experience symptoms like nasal congestion, rhinitis (hay fever, pollen allergy) or a runny nose.
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. The published article is not a medical advice by the OWNER of the "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.